vs
Kodiak Gas Services, Inc.（KGS）とBio-Techne（TECH）の財務データ比較。上の社名をクリックして会社を切り替えられます
Kodiak Gas Services, Inc.の直近四半期売上が大きい（$332.9M vs $295.9M、Bio-Techneの約1.1倍）。Bio-Techneの純利益率が高く（12.8% vs 7.4%、差は5.4%）。Kodiak Gas Services, Inc.の前年同期比売上増加率が高い（7.5% vs -6.4%）。過去8四半期でKodiak Gas Services, Inc.の売上複合成長率が高い（24.3% vs 4.2%）
コディアック・ガス・サービス社は北米を中心に事業を展開する天然ガス圧縮サービスの大手プロバイダーで、石油・ガス産業の上流・中流事業者向けに、カスタマイズされた圧縮装置、保守サポート、運用支援を提供し、陸上天然ガスの採取・処理・輸送の効率向上を支援している。
Bio-Techne社は米国発のライフサイエンス企業で、研究・診断・バイオプロセスの各市場向けに、ライフサイエンス用試薬、機器、各種サービスの開発・製造・販売を事業の柱としています。製品は基礎研究から医薬品開発、体外診断まで多岐にわたる分野で活用されています。
KGS vs TECH — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $332.9M | $295.9M |
| 純利益 | $24.6M | $38.0M |
| 粗利率 | — | 64.6% |
| 営業利益率 | 26.1% | 18.4% |
| 純利益率 | 7.4% | 12.8% |
| 売上前年比 | 7.5% | -6.4% |
| 純利益前年比 | 29.0% | 68.3% |
| EPS（希薄化後） | $0.30 | $0.24 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $332.9M | $295.9M | ||
| Q3 25 | $322.7M | — | ||
| Q2 25 | $322.8M | $317.0M | ||
| Q1 25 | $329.6M | $316.2M | ||
| Q4 24 | $309.5M | $297.0M | ||
| Q3 24 | $324.6M | $289.5M | ||
| Q2 24 | $309.7M | $306.1M | ||
| Q1 24 | $215.5M | $303.4M |
| Q4 25 | $24.6M | $38.0M | ||
| Q3 25 | $-14.0M | — | ||
| Q2 25 | $39.5M | $-17.7M | ||
| Q1 25 | $30.4M | $22.6M | ||
| Q4 24 | $19.1M | $34.9M | ||
| Q3 24 | $-5.6M | $33.6M | ||
| Q2 24 | $6.2M | $40.6M | ||
| Q1 24 | $30.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | 37.5% | 63.2% | ||
| Q2 24 | 36.5% | 66.4% | ||
| Q1 24 | 39.4% | 67.4% |
| Q4 25 | 26.1% | 18.4% | ||
| Q3 25 | 19.9% | — | ||
| Q2 25 | 30.9% | -7.5% | ||
| Q1 25 | 27.1% | 12.2% | ||
| Q4 24 | 22.3% | 16.0% | ||
| Q3 24 | 20.4% | 13.8% | ||
| Q2 24 | 17.5% | 15.0% | ||
| Q1 24 | 27.9% | 22.1% |
| Q4 25 | 7.4% | 12.8% | ||
| Q3 25 | -4.3% | — | ||
| Q2 25 | 12.2% | -5.6% | ||
| Q1 25 | 9.2% | 7.1% | ||
| Q4 24 | 6.2% | 11.7% | ||
| Q3 24 | -1.7% | 11.6% | ||
| Q2 24 | 2.0% | 13.3% | ||
| Q1 24 | 14.0% | 16.2% |
| Q4 25 | $0.30 | $0.24 | ||
| Q3 25 | $-0.17 | — | ||
| Q2 25 | $0.43 | $-0.11 | ||
| Q1 25 | $0.33 | $0.14 | ||
| Q4 24 | $0.18 | $0.22 | ||
| Q3 24 | $-0.07 | $0.21 | ||
| Q2 24 | $0.06 | $0.26 | ||
| Q1 24 | $0.39 | $0.31 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $3.2M | $172.9M |
| 総負債低いほど良い | $2.6B | $260.0M |
| 株主資本純資産 | $1.2B | $2.0B |
| 総資産 | $4.3B | $2.5B |
| 負債/資本比率低いほどレバレッジが低い | 2.12× | 0.13× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $3.2M | $172.9M | ||
| Q3 25 | $724.0K | — | ||
| Q2 25 | $5.4M | $162.2M | ||
| Q1 25 | $1.9M | $140.7M | ||
| Q4 24 | $4.8M | $177.5M | ||
| Q3 24 | $7.4M | $187.5M | ||
| Q2 24 | $3.9M | $152.9M | ||
| Q1 24 | $9.3M | $145.3M |
| Q4 25 | $2.6B | $260.0M | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.5B | $346.0M | ||
| Q1 25 | $2.6B | $330.0M | ||
| Q4 24 | $2.6B | $300.0M | ||
| Q3 24 | $2.6B | $300.0M | ||
| Q2 24 | $2.5B | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $1.2B | $2.0B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.4B | $2.1B | ||
| Q2 24 | $1.5B | $2.1B | ||
| Q1 24 | $1.1B | $2.0B |
| Q4 25 | $4.3B | $2.5B | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.4B | $2.6B | ||
| Q1 25 | $4.4B | $2.6B | ||
| Q4 24 | $4.4B | $2.7B | ||
| Q3 24 | $4.5B | $2.7B | ||
| Q2 24 | $4.4B | $2.7B | ||
| Q1 24 | $3.3B | $2.7B |
| Q4 25 | 2.12× | 0.13× | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.89× | 0.18× | ||
| Q1 25 | 1.91× | 0.16× | ||
| Q4 24 | 1.88× | 0.14× | ||
| Q3 24 | 1.86× | 0.14× | ||
| Q2 24 | 1.71× | 0.15× | ||
| Q1 24 | — | 0.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $194.9M | — |
| フリーキャッシュフロー営業CF - 設備投資 | $142.0M | — |
| FCFマージンFCF / 売上 | 42.7% | — |
| 設備投資強度設備投資 / 売上 | 15.9% | — |
| キャッシュ転換率営業CF / 純利益 | 7.91× | — |
| 直近12ヶ月FCF直近4四半期 | $284.3M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $194.9M | — | ||
| Q3 25 | $113.4M | — | ||
| Q2 25 | $177.2M | $98.2M | ||
| Q1 25 | $114.3M | $41.1M | ||
| Q4 24 | $118.5M | $84.3M | ||
| Q3 24 | $36.9M | $63.9M | ||
| Q2 24 | $121.1M | $75.5M | ||
| Q1 24 | $51.5M | $81.0M |
| Q4 25 | $142.0M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $94.6M | $93.3M | ||
| Q1 25 | $36.8M | $31.0M | ||
| Q4 24 | $45.2M | $77.5M | ||
| Q3 24 | $-49.7M | $54.7M | ||
| Q2 24 | $4.0M | $57.5M | ||
| Q1 24 | $-8.6M | $64.5M |
| Q4 25 | 42.7% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 29.3% | 29.4% | ||
| Q1 25 | 11.2% | 9.8% | ||
| Q4 24 | 14.6% | 26.1% | ||
| Q3 24 | -15.3% | 18.9% | ||
| Q2 24 | 1.3% | 18.8% | ||
| Q1 24 | -4.0% | 21.3% |
| Q4 25 | 15.9% | — | ||
| Q3 25 | 31.7% | — | ||
| Q2 25 | 25.6% | 1.5% | ||
| Q1 25 | 23.5% | 3.2% | ||
| Q4 24 | 23.7% | 2.3% | ||
| Q3 24 | 26.7% | 3.2% | ||
| Q2 24 | 37.8% | 5.9% | ||
| Q1 24 | 27.9% | 5.4% |
| Q4 25 | 7.91× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.49× | — | ||
| Q1 25 | 3.76× | 1.82× | ||
| Q4 24 | 6.21× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 19.44× | 1.86× | ||
| Q1 24 | 1.70× | 1.65× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
KGS
| Other Services | $126.8M | 38% |
| Other | $112.2M | 34% |
| Transferred At Point In Time | $93.8M | 28% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
